STOCK TITAN

Haleon sets 8.80B voting shares for FCA thresholds

Haleon plc (HLN) reported its total voting rights and share capital as of 31 August 2026.

(Neutral)
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Haleon plc (HLN) reported its total voting rights and share capital as of 31 August 2026. The company has 8,808,341,409 ordinary shares of £0.01 each in issue, of which 11,792,625 shares are held as treasury shares. This results in 8,796,548,784 ordinary shares with voting rights, which shareholders and other obliged investors should use as the denominator when calculating whether they must notify interests or changes in interests under the FCA's Disclosure Guidance and Transparency Rules.

Positive

  • None.

Negative

  • None.
Total ordinary shares issued 8,808,341,409 shares As at 31 August 2026
Treasury shares 11,792,625 shares Ordinary shares of £0.01 each held as treasury shares as at 31 August 2026
Ordinary shares with voting rights 8,796,548,784 shares Denominator for disclosure calculations under FCA rules as at 31 August 2026
Ordinary share nominal value £0.01 per share Nominal value of each ordinary share of Haleon plc
Filing date 01 September 2026 Date of the total voting rights and capital announcement
treasury shares financial
"of which 11,792,625 are held as treasury shares"
Treasury shares are a company’s own stock that it has repurchased and keeps on its books instead of canceling or leaving in the hands of outside investors. Think of them like coupons a business puts back in a drawer: they don’t vote or receive dividends while held, but they can be reissued later for employee pay or fundraising. For investors this matters because buybacks change the number of shares that count toward earnings and ownership, can boost per‑share metrics, and use corporate cash that might otherwise go to growth or dividends.
voting rights financial
"Therefore, the number of ordinary shares with voting rights is 8,796,548,784"
Voting rights are the ability of shareholders to have a say in important company decisions, like choosing leaders or approving big changes. They matter because they give owners a voice in how the company is run, similar to how voters influence elections, ensuring the company acts in shareholders’ interests.
Disclosure Guidance and Transparency Rules regulatory
"under the FCA's Disclosure Guidance and Transparency Rules"
Disclosure guidance and transparency rules are the standards and regulations that require companies to share clear, timely information about their finances, risks, operations and material events. They matter to investors because consistent, honest reporting is like a car’s dashboard — it reveals the data you need to judge safety and performance and make informed buying or selling decisions. Strong disclosure reduces surprises and helps keep markets fair and efficient.
notifiable interests regulatory
"Notifiable interests in Haleon may be sent to:"
foreign private issuer regulatory
"REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16"
A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.

FAQ

How many ordinary shares does Haleon plc (HLN) have in issue as of 31 August 2026?

As of 31 August 2026, Haleon plc has 8,808,341,409 ordinary shares of £0.01 each in issue. This total includes both shares with voting rights and shares held in treasury.

How many Haleon plc (HLN) shares are held in treasury?

Haleon plc holds 11,792,625 ordinary shares as treasury shares. Treasury shares are issued shares that the company holds itself and do not carry voting rights while held in treasury.

What is the total number of Haleon plc (HLN) shares with voting rights?

The number of Haleon plc ordinary shares with voting rights is 8,796,548,784. This figure is the total shares in issue minus the shares held in treasury and is the key denominator for disclosure calculations.

Which share count should HLN investors use for UK disclosure threshold calculations?

Investors should use 8,796,548,784 ordinary shares as the denominator to determine whether they must notify an interest in, or a change to their interest in, Haleon plc under the FCA's Disclosure Guidance and Transparency Rules.

What type of company is Haleon plc (HLN) and what markets is it listed on?

Haleon plc is described as a consumer company focused on better everyday health and is listed on the LSE and NYSE under the symbol HLN. Its brands include Advil, Centrum, Sensodyne, Panadol, Theraflu and others.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

UNITED STATES
 
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
 
FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of September 2026
 
Commission File Number: 001-41411
 
Haleon plc
(Translation of registrant’s name into English)
 
Building 5, First Floor, The Heights,
Weybridge, Surrey, KT13 0NY
(Address of principal executive offices)
 
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
 
 
Form 20-F
 
Form 40-F
 
 
 
EXHIBIT INDEX
 
Exhibit Number
Description
99.1
01 September 2026 - “Total Voting Rights and Capital”
 
  
99.1
 
 
Haleon plc: Total Voting Rights and Capital
 
01 September 2026: As at 31 August 2026 the total number of shares issued by Haleon plc ("Haleon" or the "Company") is 8,808,341,409 ordinary shares of £0.01 each, of which 11,792,625 are held as treasury shares.
 
Therefore, the number of ordinary shares with voting rights is 8,796,548,784 and this figure should be used by shareholders (and others with notification obligations) as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
 
Notifiable interests in Haleon may be sent to: company.secretary@haleon.com
 
Amanda Mellor
Company Secretary
 
About Haleon
Haleon (LSE/NYSE: HLN) is a consumer company that is solely focused on better everyday health. Our people, our brands, our research, our investment and our innovation are aimed at improving the everyday health of consumers. Our product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Our superior brands - such as AdvilCentrumOtrivinPanadolparodontaxPolidentSensodyneTheraflu and Voltaren - are trusted by more than one billion consumers and are recommended by health professionals around the world.
 
For more information, please visit www.haleon.com
 
 
 
SIGNATURE
 
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
HALEON PLC
(Registrant)
 
Date: September 01, 2026
By:
/s/ Amanda Mellor
 
 
Name:
Amanda Mellor
 
 
Title:
Company Secretary